Fennec Pharmaceuticals Inc. ( FENC) - Key Metrics
FENC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.52 | $0.06 | $0 | $0 |
| 2026Q1 | $0.44 | $0.01 | $0.07 | $0.07 |
| 2025Q4 | $0.44 | -$0.15 | -$0.19 | -$0.19 |
| 2025Q3 | $0.45 | -$0.02 | $0.05 | $0.05 |
| 2025Q2 | $0.35 | -$0.11 | -$0.13 | -$0.13 |
FENC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 47.07 |
| 2026Q1 | 0% | 265.09 |
| 2025Q4 | 0% | -11.32 |
| 2025Q3 | 0% | -102.18 |
| 2025Q2 | 0% | -17.29 |
FENC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.01% | 0% |
| 2026Q1 | 1.13% | 0% |
| 2025Q4 | -2.48% | 0% |
| 2025Q3 | 0.57% | 0% |
| 2025Q2 | -1.61% | 0% |
FENC
Price: $9.98
52 week price:
Earnings Per Share: -0.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 138134
Ebitda: -2.2 millionMarket Capitalization: 354.3 million